Inge Marie Svane

51PUBLICATIONS

225CO-AUTHORS

Tumour immunologyGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsMechanobiology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (51)

Sort by Publication Date:

|Jun 25, 2026

Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma.

|May 18, 2026

Phenotypic and Functional Characteristics of CD8+ T cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced Melanoma.

|Mar 05, 2026

Prospective study of patients with immune checkpoint inhibitor-induced hepatitis; characterization of liver injury, outcome of therapy, and management of steroid-unresponsive and steroid-dependent hepatitis.

Rikke Boedker Holmstroem, Ane Soegaard Teisner, Mark Wilhelmus Dirk Sweep

|Feb 12, 2026

Immune Cell Modulation of Patient-Matched Organoid Drug Response in Precision Cancer Medicine Platform.

Silje Kjølle, Mario Presti, Jéssica de Pina Roque

|Dec 14, 2025

Five-year clinical outcome and immune biomarkers of durable response from the MM1636 trial on IDO/PD-L1 vaccination and PD-1 blockade in first line metastatic melanoma.

Sidsel Pedersen, Mikkel Byrdal, Evelina Martinenaite

|Nov 17, 2025

β-adrenergic signaling blockade attenuates metastasis through activation of cytotoxic CD4 T cells.

Klaire Yixin Fjæstad, Astrid Zedlitz Johansen, Hannes Linder

Pageof 9

Frequent Collaborators

25 joint publications

Marco Donia

11 joint publications

Eva Ellebaek

9 joint publications

Mads Hald Andersen

9 joint publications

Özcan Met

5 joint publications

Rikke Boedker Holmstroem

Arianna Draghi

Troels Holz Borch

Mario Presti

Göran Jönsson

Jens Folke Kiilgaard

Frequent Collaborators

25 joint publications

Marco Donia

11 joint publications

Eva Ellebaek

9 joint publications

Mads Hald Andersen

9 joint publications

Özcan Met